Skip to main content
. 2017 Nov 3;9:545–554. doi: 10.2147/CLEP.S143563

Table 6.

Risk of death according to age of the individuals (exposed compared to unexposed)

Exposed, N=8,999 Unexposed, N=24,118 Crude HR p-value Adjusted HR p-value
Death in the overall population, n (%) 636 (7.0) 1,665 (6.9) 0.93 (0.85–1.02) 0.12 0.90 (0.81–1.00) 0.05
 ≤70 years 306 (4.1) 923 (4.5) 0.79 (0.69–0.90) <0.001 0.76 (0.66–0.88) <0.001
 >70 years 330 (22.3) 742 (20.6) 1.06 (0.93–1.21) 0.34 1.09 (0.93–1.26) 0.28
Death in those with newly developed cancer, n (%)a 151 (30.6) 464 (38.0) 0.74 (0.61–0.89) 0.001 0.78 (0.64–0.96) 0.02
 ≤70 years 91 (25.6) 312 (35.3) 0.64 (0.51–0.81) <0.001 0.70 (0.55–0.91) 0.007
 >70 years 60 (43.2) 152 (45.1) 1.00 (0.74–1.34) 0.98 0.98 (0.68–1.42) 0.93
Death in those without newly developed cancer, n (%)a 485 (5.7) 1,201 (5.2) 1.00 (0.90–1.11) 0.99 0.96 (0.86–1.08) 0.53
 ≤70 years 215 (3.0) 611 (3.1) 0.85 (0.72–0.99) 0.04 0.81 (0.68–0.96) 0.02
 >70 years 270 (20.1) 590 (18.0) 1.09 (0.94–1.26) 0.25 1.13 (0.96–1.33) 0.14

Notes:

a

Excluding basal cell carcinoma. Models adjusted on age, sex, underlying condition, smoking status, past history of cancer, past history of diabetes, past history of hypertension, BMI, deprivation index, and number of NSAIDs, metformin, vitamin D, glucocorticoids, methotrexate, and azathioprine prescriptions.

Abbreviations: BMI, body mass index; HR, hazard ratio; NSAIDs, nonsteroidal antiinflammatory drugs.